Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
Center for Palliative Care and Clinical Ethics, Seoul National University Hospital, Seoul, Korea.
Cancer Res Treat. 2022 Jan;54(1):20-29. doi: 10.4143/crt.2021.131. Epub 2021 Apr 12.
This study aimed to confirm the decision-making patterns for life-sustaining treatment (LST) and analyze medical service utilization changes after enforcement of the Life-Sustaining Treatment Decision-Making Act.
Of 1,237 patients who completed legal forms for life-sustaining treatment (hereafter called the LST form) at three academic hospitals and died at the same institutions, 1,018 cancer patients were included. Medical service utilization and costs were analyzed using claims data.
The median time to death from completion of the LST form was three days (range, 0 to 248 days). Of these, 517 people died within two days of completing the document, and 36.1% of all patients prepared the LST form themselves. The frequency of use of the intensive care unit, continuous renal replacement therapy, and mechanical ventilation was significantly higher when the families filled out the form without knowing the patient's intention. In the top 10% of the medical expense groups, the decision-makers for LST were family members rather than patients (28% patients vs. 32% family members who knew and 40% family members who did not know the patient's intention).
The cancer patient's own decision-making rather than the family's decision was associated with earlier decision-making, less use of some critical treatments (except chemotherapy) and expensive evaluations, and a trend toward lower medical costs.
本研究旨在确认维持生命治疗(LST)的决策模式,并分析《维持生命治疗决策法》实施后医疗服务利用的变化。
在三家学术医院完成维持生命治疗法律表格(以下简称 LST 表格)并在同一机构死亡的 1237 名患者中,纳入了 1018 名癌症患者。使用索赔数据分析医疗服务的利用和费用。
从完成 LST 表格到死亡的中位时间为三天(范围 0 至 248 天)。其中,517 人在完成文件后两天内死亡,36.1%的患者自行填写了 LST 表格。当家庭成员在不知道患者意愿的情况下填写表格时,重症监护室、连续肾脏替代治疗和机械通气的使用频率显著升高。在医疗费用最高的 10%的组中,LST 的决策者是家庭成员,而不是患者(28%的患者 vs. 32%的知道患者意愿的家庭成员和 40%的不知道患者意愿的家庭成员)。
癌症患者自己的决策而不是家庭的决策与更早的决策、某些关键治疗(除化疗外)和昂贵评估的使用减少以及医疗费用降低的趋势有关。